Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles.

Kalber TL, Ordidge KL, Southern P, Loebinger MR, Kyrtatos PG, Pankhurst QA, Lythgoe MF, Janes SM.

Int J Nanomedicine. 2016 May 9;11:1973-83. doi: 10.2147/IJN.S94255. eCollection 2016.

2.

Non-Temperature Induced Effects of Magnetized Iron Oxide Nanoparticles in Alternating Magnetic Field in Cancer Cells.

Hapuarachchige S, Kato Y, Ngen EJ, Smith B, Delannoy M, Artemov D.

PLoS One. 2016 May 31;11(5):e0156294. doi: 10.1371/journal.pone.0156294. eCollection 2016.

3.
4.

Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translation.

Li K, Gordon AC, Zheng L, Li W, Guo Y, Sun J, Zhang G, Han G, Larson AC, Zhang Z.

Nanomedicine (Lond). 2015;10(11):1761-74. doi: 10.2217/nnm.15.24.

5.

MR Imaging of Stem Cell Transplants in Arthritic Joints.

Daldrup-Link HE, Nejadnik H.

J Stem Cell Res Ther. 2014 Feb 7;4(2):165.

6.

Stem cell tracking using iron oxide nanoparticles.

Bull E, Madani SY, Sheth R, Seifalian A, Green M, Seifalian AM.

Int J Nanomedicine. 2014 Mar 31;9:1641-53. doi: 10.2147/IJN.S48979. eCollection 2014. Review.

7.

Cell labeling with magnetic nanoparticles: opportunity for magnetic cell imaging and cell manipulation.

Kolosnjaj-Tabi J, Wilhelm C, Clément O, Gazeau F.

J Nanobiotechnology. 2013;11 Suppl 1:S7. doi: 10.1186/1477-3155-11-S1-S7. Epub 2013 Dec 10.

8.

Whole body tracking of superparamagnetic iron oxide nanoparticle-labelled cells--a rheumatoid arthritis mouse model.

Markides H, Kehoe O, Morris RH, El Haj AJ.

Stem Cell Res Ther. 2013 Oct 17;4(5):126. doi: 10.1186/scrt337.

9.

Iron administration before stem cell harvest enables MR imaging tracking after transplantation.

Khurana A, Chapelin F, Beck G, Lenkov OD, Donig J, Nejadnik H, Messing S, Derugin N, Chan RC, Gaur A, Sennino B, McDonald DM, Kempen PJ, Tikhomirov GA, Rao J, Daldrup-Link HE.

Radiology. 2013 Oct;269(1):186-97. doi: 10.1148/radiol.13130858. Epub 2013 Jul 12.

10.

Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI.

Khurana A, Nejadnik H, Chapelin F, Lenkov O, Gawande R, Lee S, Gupta SN, Aflakian N, Derugin N, Messing S, Lin G, Lue TF, Pisani L, Daldrup-Link HE.

Nanomedicine (Lond). 2013 Dec;8(12):1969-83. doi: 10.2217/nnm.12.198. Epub 2013 Mar 27.

11.

MR imaging features of gadofluorine-labeled matrix-associated stem cell implants in cartilage defects.

Nejadnik H, Henning TD, Do T, Sutton EJ, Baehner F, Horvai A, Sennino B, McDonald D, Meier R, Misselwitz B, Link TM, Daldrup-Link HE.

PLoS One. 2012;7(12):e49971. doi: 10.1371/journal.pone.0049971. Epub 2012 Dec 12.

12.

The use of dopamine-hyaluronate associate-coated maghemite nanoparticles to label cells.

Babic M, Horak D, Jendelova P, Herynek V, Proks V, Vanecek V, Lesny P, Sykova E.

Int J Nanomedicine. 2012;7:1461-74. doi: 10.2147/IJN.S28658. Epub 2012 Mar 16.

13.

Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis.

Cromer Berman SM, Kshitiz, Wang CJ, Orukari I, Levchenko A, Bulte JW, Walczak P.

Magn Reson Med. 2013 Jan;69(1):255-62. doi: 10.1002/mrm.24216. Epub 2012 Feb 28.

14.

Labeling stem cells with ferumoxytol, an FDA-approved iron oxide nanoparticle.

Castaneda RT, Khurana A, Khan R, Daldrup-Link HE.

J Vis Exp. 2011 Nov 4;(57):e3482. doi: 10.3791/3482.

15.

Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging.

Jasmin, Torres AL, Nunes HM, Passipieri JA, Jelicks LA, Gasparetto EL, Spray DC, Campos de Carvalho AC, Mendez-Otero R.

J Nanobiotechnology. 2011 Feb 9;9:4. doi: 10.1186/1477-3155-9-4. Erratum in: J Nanobiotechnology. 2011;9:12. Dosage error in article text.

16.

Clinically translatable cell tracking and quantification by MRI in cartilage repair using superparamagnetic iron oxides.

van Buul GM, Kotek G, Wielopolski PA, Farrell E, Bos PK, Weinans H, Grohnert AU, Jahr H, Verhaar JA, Krestin GP, van Osch GJ, Bernsen MR.

PLoS One. 2011 Feb 23;6(2):e17001. doi: 10.1371/journal.pone.0017001.

17.

In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional label.

Sutton EJ, Henning TD, Boddington S, Demos S, Krug C, Meier R, Kornak J, Zhao S, Baehner R, Sharifi S, Daldrup-Link H.

Mol Imaging. 2010 Oct;9(5):278-90.

18.

MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritis.

Nedopil A, Klenk C, Kim C, Liu S, Wendland M, Golovko D, Schuster T, Sennino B, McDonald DM, Daldrup-Link HE.

Invest Radiol. 2010 Oct;45(10):634-40. doi: 10.1097/RLI.0b013e3181ed566c.

19.

Labeling human mesenchymal stem cells with fluorescent contrast agents: the biological impact.

Boddington SE, Sutton EJ, Henning TD, Nedopil AJ, Sennino B, Kim A, Daldrup-Link HE.

Mol Imaging Biol. 2011 Feb;13(1):3-9. doi: 10.1007/s11307-010-0322-0.

20.

Magnetization transfer imaging provides a quantitative measure of chondrogenic differentiation and tissue development.

Li W, Hong L, Hu L, Magin RL.

Tissue Eng Part C Methods. 2010 Dec;16(6):1407-15. doi: 10.1089/ten.TEC.2009.0777. Epub 2010 May 10.

Items per page

Supplemental Content

Write to the Help Desk